Literature DB >> 8690788

Atrial natriuretic peptide inhibits mineralocorticoid receptor function in rat colonic surface cells.

G Schulman1, R Lindemeyer, A Barman, S Karnik, C P Bastl.   

Abstract

Atrial natriuretic peptide (ANP) inhibits and aldosterone (ALDO) stimulates Na conductive transport. Therefore, the effects of ANP and its second messenger cGMP on mineralocorticoid receptor (MR) function in rat colon surface and crypt cells were examined. 100 nM 8-Br-cGMP decreased surface [3H]ALDO binding by 42 +/- 4% but increased crypt [3HvALDO binding by 52+/-16%. ANP decreased surface [3H]ALDO binding by approximately 50% after a 2.5-h lag period but had no effect on crypt ALDO binding. ANP and cGMP rapidly (< 15 min) inhibited surface cell ALDO-induced MR nuclear translocation but did not affect crypt MR nuclear translocation. Inhibition of cGMP-dependent protein kinase with KT5823 blocked the inhibitory effects of ANP and 8-Br-cGMP on surface cell ALDO binding and MR nuclear translocation. In crypt, KT5823 increased baseline [3H]ALDO binding but did not inhibit the stimulatory effect of exogenous cGMP. DEAE-cellulose chromatography and gel mobility shift assay showed that ANP did not inhibit surface MR activation. ANP inhibited ALDO stimulated short circuit current in distal colon. These data demonstrate cell-specific regulation of MR function. In surface cells, ANP rapidly inhibits MR nuclear translocation and ALDO-induced short circuit current. ANP inhibition of MR function may be an additional mechanism of ANP antagonism of Na reabsorption.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690788      PMCID: PMC507412          DOI: 10.1172/JCI118761

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Biochemistry, molecular biology, and physiology of the glucocorticoid receptor.

Authors:  J A Gustafsson; J Carlstedt-Duke; L Poellinger; S Okret; A C Wikström; M Brönnegård; M Gillner; Y Dong; K Fuxe; A Cintra
Journal:  Endocr Rev       Date:  1987-05       Impact factor: 19.871

2.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

Authors:  J L Arriza; C Weinberger; G Cerelli; T M Glaser; B L Handelin; D E Housman; R M Evans
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

3.  Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function.

Authors:  D J Gruol; N F Campbell; S Bourgeois
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

4.  Atrial natriuretic factor binding sites in the jejunum.

Authors:  C Bianchi; G Thibault; A De Léan; J Genest; M Cantin
Journal:  Am J Physiol       Date:  1989-02

5.  Influence of atrial natriuretic peptide on mammalian large intestine.

Authors:  K J Moriarty; N B Higgs; M Lees; A Tonge; T D Wardle; G Warhurst
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

6.  Rapid accumulation of cyclic GMP near activated vitamin D receptors.

Authors:  J Barsony; S J Marx
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Modulation of glucocorticoid receptor activity by cyclic nucleotides and its implications on the regulation of human skin fibroblast growth and protein synthesis.

Authors:  J Oikarinen; L Hämäläinen; A Oikarinen
Journal:  Biochim Biophys Acta       Date:  1984-06-15

8.  Role of glucocorticoids and aldosterone in maintenance of colonic cation transport.

Authors:  C P Bastl; H J Binder; J P Hayslett
Journal:  Am J Physiol       Date:  1980-03

9.  Regulation of aldosterone receptor in rat kidney cytosol by atrial natriuretic factor.

Authors:  M Horiuchi; N Kohashi; H Nishiyama; J Hama; T Takenaka; H Kondo; R Katori
Journal:  Hypertension       Date:  1989-04       Impact factor: 10.190

10.  Characterization of the rat colonic aldosterone receptor and its activation process.

Authors:  G Schulman; A Miller-Diener; G Litwack; C P Bastl
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.